The Valley Desk

NCT02224729 · Interventional trial

Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Overall registry status Completed

Phase 2

Conditions Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov